Home » Topics » BioWorld Science

BioWorld Science
RSS

Basilea initiates phase I/II FIDES-02 study of derazantinib in urothelial cancer

Aug. 13, 2019

Oncologie and Merck & Co. to test bavituximab plus Keytruda in gastric cancer

Aug. 13, 2019

TR-FRET-based screening identifies novel CBP bromodomain inhibitor with therapeutic potential

Aug. 13, 2019

PALM Ebola study stopped early due to favorable results for two of four candidates

Aug. 13, 2019

FDA grants accelerated approval for bedaquiline in adolescents with MDR-TB

Aug. 13, 2019

Inhibition of mitoNEET shows antileukemic activity in drug-resistant cells and in vivo models

Aug. 13, 2019

Mu-opioid receptor agonists discovered at Sichuan Kelun-Biotech Biopharmaceutical

Aug. 13, 2019

Shanghai Yingli Pharmaceutical patents TGFR-1 inhibitors

Aug. 13, 2019

Xiangbei Welman Pharmaceutical describes compounds for gout, hyperuricemia

Aug. 13, 2019

Interim data reported from phase I study of DS-Cav1 vaccine

Aug. 13, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
Taiwan biotech looks outward in next phase of growth
BioWorld
Taiwan’s biotechnology sector was built around domestic health needs, including vaccines and drug manufacturing, but it is increasingly looking outward – to...